Document is current
Any future updates will be listed below
-
Authors
Sakaguchi, Yoshihiko M.
Wiriyasermkul, Pattama
Matsubayashi, Masaya
Miyasaka, Masaki
Sakaguchi, Nau
Sahara, Yoshiki
Takasato, Minoru
Kinugawa, Kaoru
Sugie, Kazuma
Eriguchi, Masahiro
Tsuruya, Kazuhiko
Kuniyasu, Hiroki
Nagamori, Shushi
Mori, Eiichiro http://orcid.org/0000-0003-0945-196X
-
Funding
Funding for this research was provided by:
Gout and Uric Acid Foundation
Japan Society for the Promotion of Science (JP19K07373, JP22K06150, JP19K23952, JP21H03365, JP20H03199)
Japan Agency for Medical Research and Development (JP23wm0425004)
Mochida Memorial Foundation for Medical and Pharmaceutical Research
Takeda Science Foundation
Nara Medical University (Nara Medical University Grant-in-Aid for Collaborative Research Projects, Nara Medical University Grant-in-Aid for Collaborative Research Projects)
- License Information
-
More Information
Article History
Received: 16 July 2023
Accepted: 26 November 2023
First Online: 2 January 2024
Declarations
:
: Not applicable.
: Not applicable.
: E.M. received joint collaborative funding from Fuji Yakuhin, Co. Ltd. E.M. is a CEO of molmir, Inc. M.Ma. is an employee of Fuji Yakuhin, Co. Ltd.
